Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Buprenorphine 11.4mg / Naloxone 2.9mg SL tab sugar free
0410030B0AAAJAJ
|
Buprenorphine/naloxone (Opioid Dependance) | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | No data available |
|
Buprenorphine 1mg sublingual tablets sugar free
0410030A0AAAIAI
|
Buprenorphine (Opioid Dependance) | Buprenorphine hydrochloride | Central Nervous System | No data available |
|
Buprenorphine 2.9mg / Naloxone 710microgram SL tab SF
0410030B0AAAHAH
|
Buprenorphine/naloxone (Opioid Dependance) | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | No data available |
|
Buprenorphine 300micrograms/1ml inj ampoules
0407020B0AAAAAA
|
Buprenorphine (Opioid Analgesic) | Buprenorphine | Central Nervous System | No data available |
|
Buprenorphine 4mg sublingual tablets sugar free
0410030A0AAAKAK
|
Buprenorphine (Opioid Dependance) | Buprenorphine hydrochloride | Central Nervous System | No data available |
|
Buprenorphine 6mg sublingual tablets sugar free
0410030A0AAAJAJ
|
Buprenorphine (Opioid Dependance) | Buprenorphine hydrochloride | Central Nervous System | No data available |
|
Buprenorphine 74.2mg implant
0410030A0AAAWAW
|
Buprenorphine (Opioid Dependance) | Buprenorphine hydrochloride | Central Nervous System | No data available |
|
Buprenorphine 8.6mg / Naloxone 2.1mg SL tab sugar free
0410030B0AAAFAF
|
Buprenorphine/naloxone (Opioid Dependance) | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | No data available |
|
Buprenorphine 8mg / Naloxone 2mg sublingual films sugar free
0410030B0AAAEAE
|
Buprenorphine/naloxone (Opioid Dependance) | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | No data available |
|
Burinex 1mg tablets
0202020D0BBAAAE
|
Burinex | Bumetanide | Cardiovascular System | No data available |
|
Burinex 5mg tablets
0202020D0BBABAF
|
Burinex | Bumetanide | Cardiovascular System | No data available |
|
Burinex A 5mg/1mg tablets
0202040D0BBAAAA
|
Burinex-A | Amiloride hydrochloride with loop diuretics | Cardiovascular System | No data available |
|
Burinex K modified-release tablets
0202080C0BBAAAA
|
Burinex-K | Bumetanide/potassium | Cardiovascular System | No data available |
|
BurnEze 1% spray
1303000B0BDAAAI
|
BurnEze | Benzocaine | Skin | No data available |
|
Buscomint 0.2ml gastro-resistant capsules
0102000T0BLAAAA
|
Buscomint | Peppermint oil | Gastro-Intestinal System | No data available |
|
Buserelin 5.5mg/5.5ml solution for injection vials(Prostate)
0803042B0AAAAAA
|
Buserelin (Prostate) | Buserelin | Malignant Disease and Immunosuppression | No data available |
|
Busiete 10micrograms/hour transdermal patches
0407020B0BRABAI
|
Busiete | Buprenorphine | Central Nervous System | No data available |
|
Busiete 20micrograms/hour transdermal patches
0407020B0BRACAJ
|
Busiete | Buprenorphine | Central Nervous System | No data available |
|
Busiete 5micrograms/hour transdermal patches
0407020B0BRAAAH
|
Busiete | Buprenorphine | Central Nervous System | No data available |
|
Busilvex 60mg/10ml concentrate for inf ampoules
0801010B0BCAAAE
|
Busilvex | Busulfan | Malignant Disease and Immunosuppression | No data available |
|
Buspar 10mg tablets
0401020B0BBABAB
|
Buspar | Buspirone hydrochloride | Central Nervous System | No data available |
|
Buspar 5mg tablets
0401020B0BBAAAA
|
Buspar | Buspirone hydrochloride | Central Nervous System | No data available |
|
Busulfan 25mg capsules
0801010B0AAAFAF
|
Busulfan | Busulfan | Malignant Disease and Immunosuppression | No data available |
|
Busulfan 2mg/5ml oral liquid
0801010B0AAADAD
|
Busulfan | Busulfan | Malignant Disease and Immunosuppression | No data available |
|
Busulfan 60mg/10ml solution for infusion ampoules
0801010B0AAAEAE
|
Busulfan | Busulfan | Malignant Disease and Immunosuppression | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.